Vimarsana
Biggest News Aggregation in the World

Reasonable Inquiry News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Reasonable Inquiry. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Reasonable Inquiry Today - Breaking & Trending Today

Initiatives to Increase Communication Between the USPTO and the FDA Concerning Pharmaceutical Patent Applications | Dechert LLP - Vimarsana News

Initiatives to Increase Communication Between the USPTO and the FDA Concerning Pharmaceutical Patent Applications | Dechert LLP

President Biden, in July 2021, issued an Executive Order (“E.O.”) observing that “too often, patent and other laws have been misused to inhibit or delay — for years and even decades —...

PTAB Update - March 2023 | Skadden, Arps, Slate, Meagher & Flom LLP - Vimarsana News

PTAB Update - March 2023 | Skadden, Arps, Slate, Meagher & Flom LLP

Steep Drop in Discretionary Denials — But Will It Last? The Patent Trial and Appeal Board (PTAB) may be becoming more petitioner-friendly following a June 2022...

The USPTO And The FDA Join Hands To Promote Competition | MoFo Life Sciences - Vimarsana News

The USPTO And The FDA Join Hands To Promote Competition | MoFo Life Sciences

On November 15, 2022, the Berkeley Center for Law and Technology hosted a webinar to address the recent, unprecedented collaboration between the U.S. Patent and Trademark Office (USPTO)...

USPTO Underscores Duty Of Disclosure Pertaining To FDA Submissions - Patent - Vimarsana News

USPTO Underscores Duty Of Disclosure Pertaining To FDA Submissions - Patent

The USPTO has issued a Federal Register Notice discussing how the duty of candor and good faith in dealing with the USPTO applies to "information and statements material to patentability…

Source: mondaq.com
USPTO Underscores Duty of Disclosure Pertaining To FDA Submissions | Foley & Lardner LLP - Vimarsana News

USPTO Underscores Duty of Disclosure Pertaining To FDA Submissions | Foley & Lardner LLP

The USPTO has issued a Federal Register Notice discussing how the duty of candor and good faith in dealing with the USPTO applies to “information and statements material to...